Hagen Brett R

Hagen Brett R is listed in filings as Chief Accounting Officer at Kalaris Therapeutics Inc. This profile follows SEC Form 4 activity through Mar 23, 2026, including sale activity. Recent filings connect the profile to Kalaris Therapeutics Inc (KLRS). The current snapshot covers public activity from Mar 27, 2025 to Mar 23, 2026. Reported amounts are shown as $8.1K to $12.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.